Hybrid Fc‐fused interleukin‐7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy-Reference-Cited by-同舟云学术

Hybrid Fc‐fused interleukin‐7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy

Published:2020-01 Issue:9 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Kim Ji‐Hae¹,Kim Young‐Min¹,Choi Donghoon²,Jo Saet‐byeol³,Park Han Wook³,Hong Sung‐Wook⁴⁵,Park Sujeong³,Kim Sora³,Moon Sookjin³,You Gihoon³,Kang Yeon‐Woo³,Park Yunji³,Lee Byung Ha²,Lee Seung‐Woo¹³

Affiliation:

1. Laboratory of Cellular Immunology Department of Life Sciences Pohang University of Science and Technology Pohang Korea

2. Research Institute of NeoImmuneTech, Inc. Rockville MD USA

3. Laboratory of Cellular Immunology Division of Integrative Biosciences and Biotechnology Pohang University of Science and Technology Pohang Korea

4. Laboratory of T Cell Biology Division of Integrative Biosciences and Biotechnology Pohang University of Science and Technology Pohang Korea

5. Department of Microbiology and Immunology Center for Immunology University of Minnesota Medical School Minneapolis MN USA

Funder

Ministry of Education

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1168

Reference50 articles.

1. Microenvironmental regulation of tumor progression and metastasis

2. Rational combinations of immunotherapeutics that target discrete pathways

3. Myeloid-derived suppressor cells coming of age

4. Cancer immune contexture and immunotherapy

5. The immune contexture in human tumours: impact on clinical outcome

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc-fused IL-7 provides broad antiviral effects against respiratory virus infections through IL-17A-producing pulmonary innate-like T cells;Cell Reports Medicine;2024-01

2. Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity;Science Advances;2023-12

3. A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy;PLOS ONE;2023-10-24

4. Immunomodulation with IL-7 and IL-15 in HIV-1 infection;Journal of Virus Eradication;2023-09

5. A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy;2023-05-24